Educational content on VJDementia is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ARUK 2022 | Novel agents to treat psychosis in Alzheimer’s disease

Byron Creese • 1 Mar 2022
ARUK 2022
Alzheimer’s Disease Dementia Pimavanserin

Byron Creese, PhD, University of Exeter Medical School, Exeter, UK, discusses treatments for psychosis in Alzheimer’s disease that are currently being investigated. There is a great unmet need for novel treatments in this area. Pimavanserin shows promise but there is debate as to its efficacy. This interview took place at the Alzheimer’s Research UK Conference 2022 in Brighton, UK.

More from Byron Creese

Using neuropsychiatric symptoms as clinical markers for dementia diagnosis
1:05
Using neuropsychiatric symptoms as clinical markers for dementia diagnosis
Byron Creese • 17 Jul 2023
Molecular processes driving psychosis in Alzheimer’s disease
2:00
Molecular processes driving psychosis in Alzheimer’s disease
Byron Creese • 17 Jul 2023
Behavioral changes and dementia risk
2:50
Behavioral changes and dementia risk
Byron Creese • 17 Jul 2023
Pharmacological vs. non-pharmacological treatment options for psychosis in AD
1:32
Pharmacological vs. non-pharmacological treatment options for psychosis in AD
Byron Creese • 1 Mar 2022

Related Videos

A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
10:28
A multimodal model to detect and stage Alzheimer's disease using MRI, acoustic signals, and genetics
Muhammad Umar Khan • 28 Aug 2026
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
3:25
Neuroprotective effects of aortic valve replacement: a propensity score-matched cohort study
Vikash Jaiswal • 26 Aug 2026
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
2:44
Neflamapimod receives ILAP designation in the UK for dementia with Lewy bodies
Jacqui Cannon • 5 Aug 2026
The Lewy Body Society's mission and impact
2:38
The Lewy Body Society's mission and impact
Jacqui Cannon • 5 Aug 2026

Choose your cookie settings

VJDementia uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJDementia is intended for healthcare professionals